web analytics

Bloomberg Tag

Former Stryker CEO Charlie Chi Now CE(N)O- Sentenced to Two Years in Prison

June 28, 2015 2015 Startup Trend: Startup CEO’s Unemployed and or Behind Bars Evidence from The Sociopathic Business Model™ has correctly anticipated this is the year that a lot of corrupt CEO's will prove they're CE(N)O's.  Former Stryker CEO Charlie Chi from subsidiary OtisMed Corp. pled guilty in...

#CleanUpYourMeshFDA American Medical Systems Pays Mesh Victims?

October 1, 2014 Endo Said to Pay $400 Million Plus in Vaginal-Mesh Accord-Bloomberg The headlines in these cases are always deceiving and designed that way either by the companies themselves or in conjunction with the DOJ to manipulate the facts to make the victims look greedy when in fact...

Forced Accountability: Johnson & Johnson Ordered to Pay $3.27 Million over Mesh

September 5, 2014 #CleanUpYourMeshJNJ  #CleanUpYourMeshFDA   Johnson & Johnson's Ethicon's Gynecare recently used  tactics out of  The Sociopathic Business Model™:  Johnson & Johnson asked a federal judge yesterday to call off a bellwether trial in the multi-district litigation over its TVT-O pelvic mesh, arguing that plaintiff Jo Huskey failed to prove...

Johnson & Johnson’s (JNJ) DePuy Synthes Ran “Amok” Marketing Pinnacle Hips-Jury Told

September 4, 2014 #ForcedAccountabilityJNJ #PRSpinUnSpunJNJ #JNJCleanUpYourMesh #JNJExecutivesBannedForLife Johnson & Johnson's subsidiary DePuy Synthes' first of their 6,000 federal cases for a hip implant known as Pinnacle began in Dallas under U.S. District Judge Ed Kinkeade this week.  These cases are different from the Johnson & Johnson DePuy Synthes' ASR hip...

Johnson & Johnson What Doesn’t Kill YOU Makes THEM Stronger

September 2, 2014 #CleanUpYourMeshJNJ #CleanUpYourMeshFDA Johnson & Johnson's DePuy Synthes was in the news last week recalling a CMF Distraction System used on children; and, today the companies are in the news again facing a new round of lawsuits blamed for poisoning patients.  That's not to be confused...

UPDATED: Allergan, Valeant & Johnson & Johnson: Back Door Deals? Antitrust Laws?

June 23, 2014 Hey maybe someboday is paying attention!  Well at least seven U.S. senators are finally asking the right questions.  Keep Digging! UPDATED: June 26, 2014 Bloomberg-Sonali Basak Seven U.S. senators are asking federal regulators to review the potential impact of a hostile takeover by Valeant Pharmaceuticals International...